The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adjuvant sintilimab-capecitabine versus capecitabine alone in locoregionally advanced nasopharyngeal carcinoma with suboptimal response to induction chemotherapy: An open-label, randomized, controlled, phase 2 trial.
 
Li-Ting Liu
No Relationships to Disclose
 
Hai-Qiang Mai
No Relationships to Disclose
 
Qiu-Yan Chen
No Relationships to Disclose
 
Lin-Quan Tang
No Relationships to Disclose
 
Ting-Ting Quan
No Relationships to Disclose
 
Jie Chen
No Relationships to Disclose
 
Hui Cheng
No Relationships to Disclose
 
Yi-Fu Li
No Relationships to Disclose
 
Xue-Song Sun
No Relationships to Disclose
 
Linfang Wu
No Relationships to Disclose
 
Sai Lan Liu
No Relationships to Disclose
 
Shan-Shan Guo
No Relationships to Disclose
 
Rui Sun
No Relationships to Disclose
 
Xiao-Yun Li
No Relationships to Disclose
 
Wei-Xiong Xia
No Relationships to Disclose
 
Ling Guo
No Relationships to Disclose
 
Hao-Yuan Mo
No Relationships to Disclose